Scientists make life-changing discovery on treating Parkinson's disease
Scientists have made a potentially 'life-changing' discovery that could pave the way for new drugs to treat Parkinson's disease.
Experts have known for several decades that the PINK1 protein is directly linked to Parkinson's disease – the fastest growing neurodegenerative condition in the world.
Until now, no one has seen what human PINK1 looks like, how PINK1 attaches to the surface of damaged mitochondria inside of cells, or how it is activated.
But scientists have now discovered how the mutation switches on and can start using this knowledge to find a way to switch it off and slow the progression of the condition down.
Researchers at the Walter and Eliza Hall Institute, Parkinson's Disease Research Centre, in Australia, have solved the decades-long mystery.
The findings published in the journal Science reveal for the first time ever the structure of PINK1 and how it binds to mitochondria – the powerhouse of a cell – and stops it functioning properly.
Parkinson's disease can take years, sometimes decades to diagnose. Often associated with tremors, there are close to 40 symptoms including cognitive impairment, speech issues, body temperature regulation and vision problems.
The neurological condition affects around 153,000 Britons. There is currently no cure for Parkinson's, although medicine, physiotherapy and surgery can help manage symptoms.
Death of brain cells
One of the hallmarks of Parkinson's is the death of brain cells. Around 50 million cells die and are replaced in the human body every minute. But, unlike other cells in the body, when brain cells die, the rate at which they are replaced is extremely low.
When mitochondria are damaged, they stop making energy and release toxins into the cell. In a healthy person, the damaged cells are disposed of in a process called mitophagy.
In a person with Parkinson's and a PINK1 mutation, the mitophagy process no longer functions correctly and toxins accumulate in the cell, eventually killing it. Brain cells need a lot of energy and are especially sensitive to this damage.
In particular, PINK1 has been linked to young-onset Parkinson's Disease, which affects people under the age of 50. Despite the known link, researchers have previously been unable to visualise the protein or how it works.
'This is a significant milestone for research into Parkinson's. It is incredible to finally see PINK1 and understand how it binds to mitochondria,' said Professor David Komander, corresponding author on the study.
'Our structure reveals many new ways to change PINK1, essentially switching it on, which will be life-changing for people with Parkinson's,' he added.
4 steps
Lead author on the study, Dr Sylvie Callegari, said PINK1 works in four distinct steps, with the first two steps not having been seen before.
First, PINK1 senses mitochondrial damage. Then, it attaches to damaged mitochondria. Once attached, it links to a protein called Parkin so that the damaged mitochondria can be recycled.
'This is the first time we've seen human PINK1 docked to the surface of damaged mitochondria, and it has uncovered a remarkable array of proteins that act as the docking site. We also saw, for the first time, how mutations present in people with Parkinson's disease affect human PINK1,' said Dr Callegari.
The idea of using PINK1 as a target for potential drug therapies has long been touted but not yet achieved because the structure of PINK1 and how it attaches to damaged mitochondria were unknown.
The research team hope to use the knowledge to find a drug to slow or stop Parkinson's in people with a PINK1 mutation.
Researchers in the UK also believe the discovery could lead to better drug design.
Consultant neurologist Dr Richard Ellis said: 'It is a crucial step towards understanding the impact of PINK1 in Parkinson's disease. These observations may hopefully create new opportunities for developing novel strategies for slowing the progression of Parkinson's disease.'
Dr Zhi Yao, research scientist, Life Arc, said: 'A robust understanding of these aspects could present a significant opportunity for accelerating drug discovery for Parkinson's disease and potentially other neurodegenerative conditions too.'
Becky Jones, research communications manager at Parkinson's UK, said: 'Changes in the PINK1 have long been linked to Parkinson's, and a specific mutation in the gene that contains the instructions for making the protein are known to cause a rare inherited form of the condition.
'It's encouraging to see this research, which will help us understand how changes in PINK1 might be causing damage to dopamine-producing brain cells in people with Parkinson's.
'This knowledge unlocks future avenues for better drug design and discovery of a treatment that could slow or even stop Parkinson's progression. This is vital, as despite it being the fastest growing neurological condition in the world, we don't yet have any drug treatments that can do this.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
23-05-2025
- Gulf Today
Prostate cancer
We all wish President Biden the best in his journey with prostate cancer, especially those, like myself, who have also been on that journey. One of the positives that comes with his announcement is the attention that his fame will lead to others being tested and lives being saved. Similar examples include Michael J Fox with Parkinson's or Selma Blair with MS, although both of these illness have visible symptoms most of the time. There are so many diseases, many of the cancers, that are not apparent until too late and famous examples do encourage people to get checkups. Know your family medical history and get any bump, lump or spot checked. Dennis Fitzgerald, Melbourne, Australia
Zawya
22-05-2025
- Zawya
VinFuture 2025: 1,705 nominations worldwide – twelvefold increase in nominating partners over five seasons
HANOI, VIETNAM - Media OutReach Newswire - 22 May 2025 - The VinFuture Prize, a global science and technology award, has officially concluded the nomination period for its fifth season with a total of 1,705 nominations submitted from around the world. Notably, the number of official nominating partners has seen exceptional growth, reaching 14,772 – more than a twelvefold increase from the 1,200 recorded in the inaugural season – underscoring the Prize's reputation as a global hub for scientific and intellectual excellence. This season marks a significant leap in both the quantity and quality of nominations, as demonstrated by the wide engagement of the esteemed global scientific community. Among the nominating partners, the majority are from the Americas (31%), followed by Europe (28.6%), Asia (26.8%), Africa (7.1%), and Oceania (6.5%). Among the 14,772 nominators, nearly half (7,240 experts) are affiliated with leading universities and research institutes worldwide. Institutions represented include Harvard University, the Massachusetts Institute of Technology, Stanford University (USA), the University of Cambridge, the University of Oxford (UK), the University of Melbourne (Australia), the University of Toronto (Canada), and the National University of Singapore (Singapore), among others. Notably, 1,395 nominators (9.4%) are scientists ranked among the top 2% most highly cited researchers globally, based on the prestigious list compiled by experts at Stanford University. The nominations for the 2025 award season continue to span a comprehensive range of critical fields essential to human well-being and global sustainable development. These include medicine and healthcare (36.7%); energy, transportation, and construction (17.8%); environment and earth sciences (17.8%); and agriculture and food (11.3%). These core fields mirror global science and technology priorities, attracting considerable attention from the international community. VinFuture's nominating partners play a vital role in identifying and nominating groundbreaking scientific innovations for well-deserved recognition. These innovations demonstrably benefit humanity on a global scale while also amplifying the VinFuture Prize's stature within the international scientific community. Driven by the Prize's profound mission and global vision, all nominators participate on a voluntary basis. In 2024, following a nomination by Professor Monica Lam, a leading computer scientist at Stanford University (USA), Mr. Jensen Huang, CEO and co-founder of NVIDIA, was honored as one of the 2024 VinFuture Grand Prize Laureates for his industry-driven contributions to the advancement of deep learning. Dr. Thai-Ha Le, Managing Director of the VinFuture Foundation, remarked: " Our five-year commitment to the mission of 'Science for Humanity' has establisheds VinFuture as an international beacon of scientific excellence and hope. The exponential growth in nominating partners and the exceptional quality of this year's nominations not only underscore the growing trust of the international scientific community in the Prize, but also highlight the urgent need for science and technology solutions to build a world where humanity thrives in harmony with a sustainable environment." The 2025 VinFuture pre-screening round will take place from May 26 to August 31. Its goal is to enable the 10-member Pre-Screening Committee to meticulously evaluate the most impactful and award-worthy nominations for advancement to the final round. In pursuit of scientific integrity, objectivity, and transparency, the Committee will assess the nominations through a rigorous evaluation process based on the highest international standards and core criteria. These criteria include the degree of scientific or technological advancement, the impact on people's lives, and the project's scale and sustainability. Within just five years, the VinFuture Prize has rapidly established its international stature and prestige, as evidenced by the growing list of laureates honored with prestigious global accolades. Notable examples include Dr. Katalin Karikó and Prof. Drew Weissman (laureates of the 2021 VinFuture Grand Prize and 2023 Nobel Prize in Physiology or Medicine); Dr. Demis Hassabis and Dr. John Jumper (laureates of the 2022 VinFuture Special Prize and 2024 Nobel Prize in Chemistry); Prof. Geoffrey Hinton (laureate of the 2024 VinFuture Grand Prize and 2024 Nobel Prize in Physics); Prof. Yoshua Bengio, Prof. Geoffrey Hinton, Mr. Jensen Huang, Prof. Yann LeCun, and Prof. Fei-Fei Li (laureates of the 2024 VinFuture Grand Prize and 2025 Queen Elizabeth Prize for Engineering); and Prof. Daniel Joshua Drucker, Prof. Joel Francis Habener, Prof. Jens Juul Holst, and Assoc. Prof. Svetlana Mojsov (laureates of the 2023 VinFuture Special Prize and 2025 Breakthrough Prize). Hashtag: #VinFuture The issuer is solely responsible for the content of this announcement. VinFuture The VinFuture Foundation, established on International Human Solidarity Day on December 20th, 2020, is a non-profit organization co-founded by billionaire Mr. Pham Nhat Vuong and his wife, Mrs. Pham Thu Huong. The Foundation's core activity is awarding the annual VinFuture Prize, which recognizes transformative scientific and technological innovations capable of making significant positive changes in the lives of millions of people worldwide. The VinFuture Prize consists of four prestigious awards presented each year. The most esteemed prize is the VinFuture Grand Prize, valued at US$3 million, making it one of the largest annual prizes globally. Additionally, there are three Special Prizes, each valued at US$500,000, specifically dedicated to honoring Women Innovators, Innovators from Developing Countries, and Innovators with Outstanding Achievements in Emerging Fields. VinFuture
Gulf Today
13-05-2025
- Gulf Today
The reason why men are lifting weights more than ever
Ben Bryant, The Independent Paul Faulder is an enemy of cardio. 'It's a hangover from the Eighties,' he says. 'Cardio is dull as anything. I get bored out of my mind. For me, strength training feels like I'm building something that's going to last — whereas doing cardio just feels like burning fuel.' Some might find running appealingly meditative but for Faulder, there is nothing more mindful than perfecting the art of the incline dumbbell press. 'It is a real mindfulness-focused activity,' he explains. 'You pinch your shoulder blades back together. You point your elbows at 45 degrees. You start with the dumbbell over your wrists. Drive your heels through the floor. And now do your set. And by the end of it, you're adding the tempo of a one-second or three-second pause.' I am taking notes because Faulder is a gains guru. Only a few years ago, he was an 18-stone 'depressed Teletubby' with chronic pain. At the end of Covid-19, he decided to sign up with a personal trainer and fulfil a decades-old dream of becoming as jacked as Arnold Schwarzenegger in Conan the Barbarian. His pictures show that he has achieved his desire: four years on, he stands at six foot four with eight per cent body fat, and a body like a giant baggie of gleaming bronze conkers. 'The benefits it's brought me in business are just phenomenal,' he says. 'It's brought me a new level of mental clarity and focus. I've got loads of energy and people respond to that.' As the CEO of a tech company — Elixir software, which provides software to global pharmaceutical/biotech firms — Faulder has a demanding schedule. He has shaped his company in the image of his sculpted body: 'a lean, potent team that outperforms bloated, sluggish organisations.' And that includes requesting an unusual level of accountability for his board of directors. 'I've now got all my board having full blood panels,' he says. Wealthy businessmen used to be called fat cats for a reason: there was a time when men at the top of the status tree had a bulging waistline to match their wallets. These days, finance bros deadlift, wear slim-fit quarter-zips, idolise Patrick Bateman and post topless TikToks. Everywhere you look, male role models from neuroscientist Andrew Huberman and fitness influencer Chris Williamson to esteemed statistician Nassim Nicholas Taleb are extolling the benefits of lifting weights, and Gen Z is taking note. Record numbers of Britons are going to the gym, with a 'notable rise in the popularity of strength training', according to trade body UKActive. PureGym's annual statistical report found that a remarkable 89 per cent of 18- to 24-year-olds do some form of strengthening exercise every week. In 2022, ClassPass reported a 94 per cent increase in strength training class reservations compared to the previous year. 'Lately, there's a noticeable shift,' says Daniel Herman, a National Academy of Sports Medicine (NASM) fitness coach and founder of Finchley sports nutrition company Bio-Synergy. 'More men are asking for muscle-building programmes, even those who used to be all about running or cycling. There's a broader cultural interest in strength and a desire to look like they train. 'Leaner but more muscular' is a phrase I hear a lot. They're also often interested in optimising energy, mood, and longevity, not just aesthetics.' Most of Herman's clients are aged between 25 and 45, and in white-collar industries like finance, tech, law and startups. He sees different patterns in the people he coaches. 'Finance guys tend to want visible results fast. Think lean, defined, 'cover model' look,' he says. 'They like numbers and benchmarks: how much they lift, how much they weigh, their body fat percentage. Tech guys often come from a more sedentary baseline and want to undo the desk job.' He goes on to explain that many of these tech guys start with posture correction and general strength, then transition into hypertrophy — the growth of muscle — once they see initial progress. This represents a challenge to the brainless jock stereotype, which has deep roots. As far back as medieval Britain, men with muscles who toiled in the fields carried the signals of inferior class status on their bodies; physical frailty was a luxury of the effete aristocracy. Today, London's affluent elite are still shy when it comes to strength training. You can find them running or cycling, or perhaps doing high-intensity workouts like F45 and Barry's Bootcamp. Getting shredded is often framed as brutish, tragic or cringe – think Andrew Tate, Zac Efron, or Patrick Schwarzenegger in The White Lotus, whose twinky brother, tellingly, is almost killed by a protein shake. However, muscles remain an ambiguous symbol of male status. Nowhere is that clearer than in the minds of the most assiduous judges of men: women. A recent X/Twitter poll showed women two pictures of Olly Murs, who has recently undergone a bodily transformation. They were asked whether he was more attractive in his pudgy 'before' photo or his sculpted 'after' shot. The women overwhelmingly picked the former. Too much muscle, my female friends assure me, suggests someone who is vain, a try-hard lacking in spontaneity. The most popular heartthrobs of the current era are often built less like gladiators and more like Roman towel boys — see Timothée Chalamet, Harry Styles or Kit Connor. This is an outcome that confounds the kind of men who prefer the sureties of hard data to the mysterious and capricious desires of women. For them, the mounting evidence that the jocks were right all along is becoming harder to ignore – and now data-driven nerds from Bezos to Zuckerberg are defecting to meathead territory.
